Clinical Trials Logo

Clinical Trial Summary

Our earlier research has highlighted a high prevalence of anaemia, micronutrient deficiencies, and impaired infant growth among lactating women and infants in Sumedang district, West Java, Indonesia that were associated with large deficits in their micronutrient intakes. In response to these disturbing findings we have developed the micronutrient- enriched crackers (MEC) based on powdered eggshells and chicken liver, a readily available and affordable, local animal-source food. We will supply these MEC or a placebo, manufactured locally, weekly to a group of women in Sumedang district from 8-14 weeks gestation to 5 months post-partum in an effort to enrich the micronutrient content of the daily diets of the treatment group so they no longer have any dietary shortfalls in micronutrients. Our overall aim is to determine if MEC consumed daily by mothers for 6 months during pregnancy improves the birth length of their infants, and if daily consumption of MEC is continued daily to 5 months post-partum enhances infant linear growth compared to the placebo. This study is funded by the UK Wellcome Trust, the grant reference number is 216447/Z/19/Z.


Clinical Trial Description

A double-blind two-phase cluster randomized controlled trial (RCT) will be conducted in West Java, Indonesia to determine whether daily consumption of MEC from 8-14 weeks' gestation to delivery improves birth length compared to placebo (Phase 1) and whether daily consumption of MEC from 8-14 weeks gestation to 5 months post-partum improves attained linear growth of infants at age 5 months and linear growth velocity of infants from birth to age 5 months compared to placebo (Phase 2). A total of 324 pregnant women will be recruited through midwives/public health centre from 28 clusters (villages) in Sumedang district. Clusters will be randomly assigned to receive placebo or micronutrient- enriched crackers (MEC) daily, distributed by cadres from 8-14 weeks gestation to 5 months post-partum. Women who fulfil trial criteria will be invited to participate in the RCT. Placebo and MEC (based on powdered eggshells and chicken liver) will be manufactured locally according to Standard Operational Procedures (SOPs), so they are identical in size, color, and packaging, with a code known only by the local production manager. The code will not be shared until the primary outcome has been analysed statistically or if requested by the Ethics Committee and/or Data Safety Monitoring Board (DSMB). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04564222
Study type Interventional
Source SEAMEO Regional Centre for Food and Nutrition
Contact
Status Active, not recruiting
Phase N/A
Start date November 11, 2020
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Completed NCT00379158 - Comparison of the Efficacy and Acceptability of Three Types of Micronutrient Supplements in Ghana Phase 4
Completed NCT04734938 - The Effect on Micronutrient Status of a Diet of 100% Huel N/A
Active, not recruiting NCT06146452 - Micronutrient Status in Pediatric Palliative Care
Completed NCT00872365 - Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases N/A
Completed NCT01140256 - Longitudinal Zinc Intakes and Exchangeable Zinc Pool Sizes in Breastfed Small for Gestational Age vs Appropriate for Gestational Age Infants in Pakistan N/A
Completed NCT03422809 - Cyclic Variation in Micronutrient Concentrations and Plasma Volume
Completed NCT04288544 - "Health Promoting Effects of the Microalgae Phaeodactylum Tricornutum" N/A
Completed NCT05857345 - Breastmilk as a Source of Lactocytes